West Pharmaceutical Services Inc (WST)
338.42
+10.25
(+3.12%)
USD |
NYSE |
Jun 12, 16:00
338.56
+0.14
(+0.04%)
Pre-Market: 20:00
West Pharmaceutical Services Accounts Receivable (Quarterly): 524.00M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 524.00M |
December 31, 2023 | 512.00M |
September 30, 2023 | 519.10M |
June 30, 2023 | 534.40M |
March 31, 2023 | 513.40M |
December 31, 2022 | 507.40M |
September 30, 2022 | 485.30M |
June 30, 2022 | 528.40M |
March 31, 2022 | 498.70M |
December 31, 2021 | 489.00M |
September 30, 2021 | 476.40M |
June 30, 2021 | 480.50M |
March 31, 2021 | 465.70M |
December 31, 2020 | 385.30M |
September 30, 2020 | 373.00M |
June 30, 2020 | 340.60M |
March 31, 2020 | 333.00M |
December 31, 2019 | 319.30M |
September 30, 2019 | 316.10M |
June 30, 2019 | 330.80M |
March 31, 2019 | 318.20M |
December 31, 2018 | 288.20M |
September 30, 2018 | 302.90M |
June 30, 2018 | 296.70M |
March 31, 2018 | 290.40M |
Date | Value |
---|---|
December 31, 2017 | 253.20M |
September 30, 2017 | 251.80M |
June 30, 2017 | 242.40M |
March 31, 2017 | 224.80M |
December 31, 2016 | 200.50M |
September 30, 2016 | 209.50M |
June 30, 2016 | 219.00M |
March 31, 2016 | 209.60M |
December 31, 2015 | 181.40M |
September 30, 2015 | 194.60M |
June 30, 2015 | 198.80M |
March 31, 2015 | 189.50M |
December 31, 2014 | 179.00M |
September 30, 2014 | 195.90M |
June 30, 2014 | 209.60M |
March 31, 2014 | 208.70M |
December 31, 2013 | 185.70M |
September 30, 2013 | 198.20M |
June 30, 2013 | 195.30M |
March 31, 2013 | 189.00M |
December 31, 2012 | 175.00M |
September 30, 2012 | 182.90M |
June 30, 2012 | 185.00M |
March 31, 2012 | 176.00M |
December 31, 2011 | 147.20M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
316.10M
Minimum
Sep 2019
534.40M
Maximum
Jun 2023
446.62M
Average
482.90M
Median
Accounts Receivable (Quarterly) Benchmarks
Abbott Laboratories | 6.605B |
Becton Dickinson & Co | 2.559B |
Intuitive Surgical Inc | 1.029B |
Merit Medical Systems Inc | 180.66M |
Perspective Therapeutics Inc | 0.999M |